PROK
ProKidneyยทNASDAQ
--
--(--)
--
--(--)
PROK Profile
Prokidney Corp.
A US-based biotech company that develops and commercializes novel therapies for chronic kidney disease
Biological Technology
02/25/2021
06/30/2021
NASDAQ Stock Exchange
231
12-31
Common stock
2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, NC 27103
--
ProKidney Corp. was incorporated under the laws of the Cayman Islands on February 25, 2021. The Company is a late-stage clinical biotechnology company that has pioneered the development of a first-in-class autologous cell therapy designed to protect kidney function in patients with advanced chronic kidney disease (" CKD ") and diabetes.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
